Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis
Clinical trial NCT04807972 · TERMINATED
Trial details
- NCT number
- NCT04807972
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2024-03-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.